NCT01435486 - Caffeine Citrate for the Treatment of Apnea Associated With Bronchiolitis in Young Infants | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

May 31, 2014

Study Completion Date

November 30, 2014

Conditions

BronchiolitisApneaCaffeine

Interventions

DRUG

Caffeine citrate

Single stat dose (25 mg per kilogram of body weight) of intravenous caffeine citrate (25mg caffeine citrate equal to 12.5mg caffeine base).

DRUG

Normal saline

Placebo with an equivalent volume of normal saline.

Trial Locations (1)

Pediatric emergency center, Hamad Medical Corporation, Doha